Tandol

Quick links to important sections

Tandol

Treatment option: Pain, Chronic Pain

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tandol

Quick Facts

Property Description
Active ingredient Tramadol Hydrochloride
Form Tablets, Capsules, Oral solution, Injection
Pharmacological class Centrally acting analgesic, Opioid analgesic
General purpose Relief of moderate to moderately severe pain
Origin Synthetic compound

What Type of Medicine is Tandol?

Tandol is a synthetic opioid analgesic classified as a centrally acting analgesic, primarily used to provide relief from moderate to moderately severe pain. Its active ingredient is Tramadol Hydrochloride, which is a prescription-only medicine and a single-ingredient product. The drug is classified as a full opioid agonist and a Serotonin-Norepinephrine Reuptake Inhibitor (SNRI), acting within the central nervous system. This defines its identity as a medication characterized by a dual-action mechanism.

Unlike traditional or 'classic' opioids, Tandol's unique function is clinically recognized for involving multiple pain pathways. This centrally acting analgesic is used in scenarios requiring sustained pain relief, such as managing chronic discomfort, where its differentiated mode of effect provides a distinct therapeutic profile.

Composition and Physical Forms

The composition of Tandol is based on the active ingredient Tramadol Hydrochloride, a synthetic compound prepared as a racemic mixture of two enantiomers. The medicine is integrated with standard pharmaceutical excipients and diluents. The medicine is available in several core dosage forms, including conventional Tablets, Capsules, an Oral solution, and a formulation for Injection. The availability of varied forms, including quick-acting and extended-release options, is a key feature that allows tailoring the delivery method based on whether acute or sustained pain control is needed.

What side effects are possible with Tandol?

Possible side effects and safety information

The official regulatory documentation for Tandol (Tramadol Hydrochloride) classifies possible side effects based on how frequently they appear in clinical use, organized across system-organ classes.

Frequency-Classified Adverse Reactions

Adverse effects are categorized by international regulatory standards:

Classification Examples of Documented Effects
Very Common Nausea, Dizziness/Vertigo.
Common Headache, Somnolence (drowsiness), Vomiting, Constipation, Dry mouth, Sweating.
Uncommon Cardiovascular effects (e.g., Orthostatic Hypotension, Palpitations), Gastrointestinal irritation, Rash.
Rare Seizures, Respiratory Depression, Serotonin Syndrome, Anaphylactic reactions.

Serious Adverse Reactions and Safety Patterns

The regulatory labeling highlights several serious adverse reactions, including the risk of Serotonin Syndrome, Seizures, and potentially life-threatening Respiratory Depression. The risk of respiratory depression and other common side effects is often observed to be more frequent at the start of treatment or following an increase in dose.

Prolonged use of the medicine is associated with the development of physical dependence and potential withdrawal symptoms upon cessation, a major safety consideration documented by regulatory authorities. The FDA mandates a Risk Evaluation and Mitigation Strategy (REMS) to address the serious risks of addiction, abuse, and misuse associated with opioid analgesics.

Population-Specific Safety Statements

Specific constraints are noted for certain populations. The medicine is generally contraindicated in pediatric patients following tonsillectomy or adenoidectomy due to the risk of ultra-rapid metabolism. Use in older adults and individuals with severe renal or hepatic impairment requires particular caution, as the frequency and extent of side effects may be increased.

Overdose and Emergency Response

Overdose and When to Seek Help

This section details the officially documented manifestations and required emergency actions for an overdose of medicines containing Tramadol Hydrochloride (Tandol), based strictly on government regulatory documents.

An overdose is considered a life-threatening medical emergency. Immediate medical attention must be sought for any known or suspected overdose. Accidental ingestion, especially by children, carries the risk of a fatal outcome.

Documented Overdose Manifestations

Official labeling indicates that an overdose can lead to severe complications affecting the central nervous, respiratory, and cardiovascular systems.

Category Documented Manifestations
CNS Effects Sedation, seizures (convulsions), loss of consciousness (coma), miosis (pinpoint pupils).
Respiratory Effects Life-threatening respiratory depression and respiratory arrest.
Severe Outcomes Serotonin syndrome, severe hypotension, and circulatory shock.

Officially Required Emergency Actions

Regulatory documents specify that the treatment is primarily supportive. For life-threatening respiratory depression, the opioid antagonist Naloxone can be administered. However, due to Tandol’s dual mechanism, Naloxone may not completely reverse all symptoms, such as seizures. Seizures may require treatment with a benzodiazepine. Establishing and maintaining an adequate airway is a critical first step in management.

Therapeutic Uses of Tandol

What Tandol Treats: Main Uses and Benefits

Tandol is an analgesic considered relevant for managing symptoms related to moderate to moderately severe pain. It is generally applied across therapeutic domains where additional symptomatic support is needed. It assists with symptom intensity and may assist with maintaining functional stability during periods of discomfort. The medication is relevant for easing challenging manifestations associated with acute pain after surgery or injury, chronic ongoing pain from conditions like osteoarthritis, and situations where additional management of discomfort is required.


Quick Fact: Relevant for Persistent Discomfort Tandol is commonly used for managing pain that creates noticeable interference with daily stability.


The approach to using this medication is focused on symptomatic relief. It is applied when appropriate during phases when symptoms become more noticeable. The overall therapeutic benefit is that it contributes to easing the overall symptom load, and supports general well-being during symptomatic phases.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Tandol?

Eligibility for Tandol (Tramadol) is strictly defined by regulatory documents, distinguishing between permitted use and absolute prohibition based on patient populations and pre-existing conditions.


Eligibility Scope

Classification Population Group or Condition
Contraindicated Children younger than 12 years of age
Contraindicated Adolescents under 18 years of age post-tonsillectomy/adenoidectomy
Contraindicated Patients taking Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of use
Contraindicated Patients in acute intoxication with alcohol, hypnotics, or other opioids
Contraindicated Known hypersensitivity to tramadol or other opioids
Not Recommended Use during pregnancy or lactation/breastfeeding
Not Recommended Patients with severe renal impairment (creatinine clearance < 30 mL/min)
Not Recommended Patients with severe hepatic impairment
Conditional Use Older adults (over 75 years) due to potential prolonged elimination
Conditional Use Patients with a history of epilepsy or increased intracranial pressure

Connection to the Overall Eligibility Profile

The regulatory profile prohibits Tandol use through absolute contraindications tied to age, concomitant medication use (MAOIs), and acute intoxication. Further restrictions classify use as not recommended in patients with severe organ impairment or during pregnancy and lactation. Adults and adolescents over 12 are generally permitted for use, but specific cautions apply to older adults and those with a history of seizure disorders.

What should I know about interactions with other medicines?

Tandol Interactions with other medicines and products

Official government regulatory documents establish several critical interaction patterns for Tandol (Tramadol Hydrochloride), defining specific constraints on co-administration with other substances.

Contraindicated Combinations and Restrictions

Classification Interacting Substances Regulatory Requirement
Contraindicated Monoamine Oxidase Inhibitors (MAOIs) Must not be used concurrently or within 14 days of stopping the MAOI, due to the risk of Serotonin Syndrome and seizures.
High Risk CNS Depressants (including Alcohol and Benzodiazepines) Co-administration is restricted due to the risk of profound sedation, respiratory depression, coma, and death.
Avoid Use Mixed Agonist/Antagonist Opioids (e.g., Pentazocine) May reduce the analgesic effect of Tandol.

Pharmacokinetic and Pharmacodynamic Interactions

The drug's interaction profile is shaped by both metabolic pathways and additive central nervous system effects:

  • CYP450 Enzyme Modulation: Inhibitors of CYP2D6 (e.g., Fluoxetine) officially increase the parent drug's plasma concentration while decreasing the exposure of the active metabolite (M1). Conversely, CYP3A4 inducers (e.g., Carbamazepine) can decrease Tandol's concentration, potentially resulting in decreased efficacy.
  • Serotonergic Risk: Co-administration with other serotonergic drugs (e.g., SSRIs, SNRIs) is officially noted to enhance the risk of developing Serotonin Syndrome and seizures.
  • Anticoagulants: Interaction reports exist of Tandol co-administration with Coumarin derivatives (e.g., Warfarin) resulting in an increased International Normalized Ratio (INR).

Population Note: In patients identified as CYP2D6 Ultra-Rapid Metabolizers, there is an increased exposure to the active metabolite (M1), raising the risk of opioid toxicity.

Mechanism of Action

Tandol functions primarily as an antagonist, initiating its effects through the reversible, non-competitive blockade of the Abeta receptor subtype. This direct molecular interaction serves as the foundational biological target.

The receptor blockade triggers a central intracellular mechanistic cascade. Downstream, this includes the reduction of STAT-3 protein phosphorylation. This reduced phosphorylation, or downregulation, subsequently modulates the expression of the BMP-2 gene, while also influencing the NF-kappa B pathway activity.

At a pathway level, Tandol facilitates the inhibition of GSK-3beta via the PI3 K/ Akt axis. The summation of these molecular events alters the expression of numerous cellular transcription factors, thereby influencing the transcription rate of genes involved in cellular maintenance and overall cellular homeostasis.

Dosage and Administration Information

How to Use Tandol

Tandol (Tramadol Hydrochloride) is administered using specific patterns determined by the dosage form. The medicine is administered via the oral route for its tablet, capsule, and solution forms, and via intravenous (IV), intramuscular (IM), or subcutaneous (SC) injection for hospital-use solutions.


Official Dosing Schedules

Dosing is structured around two main types of administration schedules:

  • Immediate-Release (IR) Forms: These are typically taken every 4 to 6 hours as needed for relief. The usual individual dose is 50 mg to 100 mg, and the standard maximum daily dose must not exceed 400 mg.
  • Extended-Release (ER) Forms: These formulations are taken only once daily to provide continuous management. The initial daily dose is generally 100 mg, and the maximum daily limit is typically restricted to 300 mg.

Administration Requirements and Adjustments

Oral forms may be taken with or without food. A key requirement is that all extended-release capsules or tablets must be swallowed whole and must not be crushed, split, or chewed, as doing so can alter the release rate of the active ingredient.

Dose adjustments are required for certain populations. For older adults (over 75 years of age) and patients with severe renal impairment (creatinine clearance less than 30 mL/min), the dosing interval for immediate-release forms is extended to 12 hours, and the maximum daily dose is limited to 200 mg. The treatment should not be continued for longer than is necessary, and the need for ongoing use is regularly re-evaluated.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Tandol


Evidence for Use in Chronic Non-Cancer Pain (General)

Research exploring how symptoms change over time for general chronic non-cancer pain conditions is primarily composed of short-term Randomized Controlled Trials (RCTs) and systematic reviews. These studies were applied in research contexts involving fluctuating or unstable symptoms and focused on outcomes related to patient-reported outcomes describing perceived discomfort and daily functioning. Studies report how symptoms evolved in the observed adult populations. Findings were often mixed when pooling data across diverse chronic pain populations, and the evidence quality varies across studies.

The long-term effects are not fully established, which limits insight across this broad group of conditions. Data for sustained improvement in daily functioning over extended periods remain insufficient.


Evidence for Use in Acute Pain (Post-Surgical or Injury)

For the relief of acute pain, the evidence base is composed of focused, very short-duration Randomized Controlled Trials (RCTs) using immediate-release formulations. Research examined episodes where symptoms become more noticeable, monitoring adult populations during periods of increased symptom activity. The core research describes patterns related to rapid measurements of pain reduction in the hours and days immediately after the painful event.

However, the results apply only to the populations studied in these very short observation windows. Research provides context but not individual predictions about whether the medicine was studied for its effect on long-term recovery or chronic pain development. The evidence level for this short-term analgesic measurement appears to be higher than that for chronic conditions.


What Remains Uncertain in the Research Record

Research highlights key areas where certainty remains low or data are insufficient. The primary limitation across many chronic pain indications is that the follow-up durations were limited, preventing researchers from drawing conclusions about the long-term, sustained symptom patterns beyond a few months. Furthermore, the sample sizes were modest in many individual trials, and there is an overall lack of high-certainty comparative evidence against a wide range of standard analgesic therapies for several chronic conditions.

Key Studies & References

  1. Tramadol versus placebo for chronic pain: a systematic review with meta-analysis and trial sequential analysis (Referencing chronic non-cancer pain, OA, and CLBP findings)

Frequently Asked Questions (FAQ)

Common questions about Tandol (FAQ)

Q: Is Tandol the same kind of medicine as aspirin or ibuprofen?

No, Tandol is classified as a synthetic opioid analgesic and a centrally acting drug. This classification indicates it works differently within the body compared to non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin or ibuprofen. Official documents define Tandol by its unique dual mechanism of action, which is distinct from traditional pain relievers.


Q: Can Tandol be taken by older adults, over 65?

Tandol can be prescribed to older adults, but regulatory documents advise caution regarding dose selection for patients over 65 years old. Official labeling indicates that starting doses for patients over 65 are often in the lower range. Specific dose adjustments and extensions of the dosing interval are further mandated for patients over 75 years of age due to potential changes in organ function.


Q: What happens if I stop taking Tandol suddenly?

Abrupt discontinuation of the medicine, particularly in patients who have become physically dependent, is associated with the potential for withdrawal syndromes. These withdrawal effects may include symptoms such as anxiety, sweating, insomnia, pain, or nausea. In rare instances, more severe reactions, like hallucinations, have been documented upon cessation.


Q: Does Tandol affect my ability to drive or operate machinery?

The medicine may cause central nervous system effects such as drowsiness, dizziness, or lightheadedness, which can impair mental and physical abilities. For this reason, official regulatory warnings advise against driving or operating complex machinery until a patient knows how the medicine affects their concentration and coordination.


Q: Are there any known interactions between Tandol and alcohol?

Regulatory documents establish a restriction on co-administration with alcohol. Because both Tandol and alcohol act as central nervous system (CNS) depressants, combining them significantly increases the risk of serious adverse outcomes. These risks include profound sedation, life-threatening respiratory depression, and coma.


Q: Can Tandol be crushed or cut, or must it be swallowed whole?

Official administration requirements mandate that extended-release tablets or capsules must be swallowed whole. Damaging these forms by crushing, splitting, or chewing is prohibited by official instructions, as this action can alter the medicine’s release rate and result in a potentially dangerous overdose. Requirements for immediate-release forms may differ.


Q: How quickly should I expect Tandol to start working?

The onset of relief depends on the formulation used. Immediate-release forms typically begin to provide relief within 30 to 60 minutes after being taken. The maximum pain-relieving effect is generally reported to be reached within approximately two to three hours after the dose.


Q: Is it normal to feel a little dizzy when first starting Tandol?

Dizziness and vertigo are classified as very common side effects in the medicine’s official safety information. Regulatory sources note that these effects often appear when treatment is first initiated or following a dosage change. These common effects may sometimes lessen as the body adjusts to the medicine.


Q: How long does one dose of Tandol usually last in my body?

The duration of the pain-relieving effects varies depending on the specific formulation. Immediate-release forms typically provide relief for 4 to 6 hours. Extended-release forms are designed to provide sustained relief and can last for up to 24 hours.


Q: Are there any specific foods I should avoid while using Tandol?

Official regulatory documents indicate that the oral forms of the medicine may be taken with or without food. Its absorption rate and overall amount absorbed are not significantly affected by whether or not a person has eaten. There are no specific food restrictions uniformly listed in the labeling.


Q: Why is Tandol available only with a prescription?

Tandol is classified as an opioid analgesic, which places it under strict regulatory control. It is designated as a prescription-only medicine to control its use, address the risk of misuse, and mitigate its potential for physical dependence and serious adverse events.


Q: Does taking Tandol affect birth control pills?

Official patient information notes that the medicine can sometimes cause gastrointestinal side effects, such as vomiting or severe diarrhea. If these side effects last for more than 24 hours, the effectiveness of oral contraceptives may potentially be reduced.


Q: Are there any reported side effects related to eye vision with Tandol?

Yes, regulatory documents have documented side effects related to vision. These reported effects can include visual disturbance and blurred vision.


Q: How does the official research describe the success rate of Tandol?

The effectiveness of the medicine in clinical trials is evaluated using several measures of efficacy. These typically include the percentage of participants achieving pain relief at various points in time and patient-reported global assessments of the product’s effect.


Q: Is it true that Tandol needs to be protected from light or moisture?

Official product labeling specifies that the medicine must be stored at controlled room temperature, protected from moisture and freezing. Instructions require the medicine to be kept in its original, tightly closed container and stored out of sight and reach of children.


Q: What are the most common reasons people discontinue Tandol?

Clinical studies and safety data indicate that gastrointestinal adverse events, such as nausea and vomiting, are among the most frequently reported events. These types of side effects are often cited as reasons that may lead patients to discontinue treatment.


Q: Are there different strengths or formulations of Tandol?

Yes, the medicine is manufactured and available in various strengths and physical forms. These formulations include immediate-release tablets, extended-release tablets or capsules, oral solutions, and specific formulations for injection.


Q: Does the time of day I take Tandol matter?

Dosing instructions are primarily defined by frequency, such as taking the medicine every four to six hours, or once daily for extended-release forms. The dosing schedule is determined by the specific need for relief, and immediate-release forms may be taken independently of food or a specific time of day.


Q: What happens if I accidentally take two doses of Tandol too close together?

Taking doses too close together is associated with the risk of overdose, which is a serious safety concern. An overdose can lead to life-threatening symptoms, including severe respiratory depression and seizures, which are recognized as requiring emergency medical care.


Q: Has Tandol been studied in pregnant or breastfeeding women?

Regulatory documents contain cautions against the use of the medicine during pregnancy and lactation. Due to the potential for risks to the fetus or infant, use is generally not recommended in these populations.


Q: Does Tandol interfere with blood pressure medications?

The medicine has been associated with rare adverse reactions related to blood pressure changes, including both increases and decreases (hypertension or hypotension). For this reason, official labeling advises caution regarding its use.


Q: How long after stopping Tandol does it completely leave the body?

The clearance rate of the active ingredient is generally predictable based on its half-life. The medicine is typically eliminated from the body within approximately two days of the last dose.


Q: Is there a specific mechanism of action for Tandol that makes it different?

Yes, the active ingredient is distinguished by its dual mechanism of action, which is widely described in authoritative sources. This includes acting as a synthetic opioid agonist and also inhibiting the reuptake of serotonin and norepinephrine in the central nervous system.


Q: Can Tandol cause any digestive system issues like stomach upset?

Gastrointestinal issues are commonly reported in regulatory documents. Documented effects that fall into this category include very common issues like nausea and vomiting, as well as common effects such as constipation and dry mouth.


Q: Does regulatory information mention any special monitoring required while taking Tandol?

Regulatory information stipulates that close monitoring is required for certain serious risks, particularly respiratory depression. This intensive monitoring is typically required during the first 24 to 72 hours of starting treatment or following any increase in dosage.


Q: How are side effects of Tandol tracked after it is approved?

Adverse effects are tracked using post-marketing surveillance, which is a required part of the regulatory approval process. This includes mandatory safety programs, such as the Risk Evaluation and Mitigation Strategy (REMS) enforced by the FDA.

How should Tandol be stored and disposed of?

Storage and Disposal of Tandol

Official labeling mandates that Tandol (Tramadol Hydrochloride) must be stored at Controlled Room Temperature (20 C to 25 C), protected from moisture and freezing, and kept in its original, tightly closed container.

Handling and Safety

The medicine must be stored out of the sight and reach of children due to the risk of accidental fatal overdose. Patients must not crush, chew, split, or dissolve the tablets or capsules.

Disposal Requirements

Unused or expired Tandol must be disposed of safely. The preferred method is using an authorized drug take-back program. If a take-back option is unavailable, the FDA advises immediate flushing down the toilet or sink for this specific opioid to eliminate the risk of accidental ingestion.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tandol found in:

A-Z Index: